Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Current Cancer Drug Targets|February 10, 2021
Cholangiocarcinoma Therapeutics: An UpdateMai Ly Thi Nguyen, Nguyen Linh Toan, Maria Bozko, et al.Experimental Cell Research|October 22, 2019
Hypoxia induced Sonic Hedgehog signaling regulates cancer stemness, epithelial-to-mesenchymal transition and invasion in cholangiocarcinomaVikas Bhuria, Jun Xing, Tim Scholta, et al.Cancer Letters|April 15, 2017
Therapeutic effects of Argyrin F in pancreatic adenocarcinomaXi Chen, Khac Cuong Bui, Samarpita Barat, et al.Bratislavske Lekarske Listy|May 17, 2024
Hyponutrition among newly diagnosed gastric cancerVan Tran Pham, Mai Ly Thi Nguyen, Chi Pham, et al.Medicine|November 5, 2025
Dynamic alterations in plasma adiponectin levels after surgery as a prognostic factor for gastric cancer: A prospective cohort studyDoanh Hieu Tran, Thanh Son Le, Trong Hoe Nguyen, et al.Journal of Gastroenterology and Hepatology|October 22, 2020
Targeting interleukin 6 signaling by monoclonal antibody siltuximab on cholangiocarcinomaMai Ly Thi Nguyen, Khac Cuong Bui, Tim Scholta, et al.Anticancer Research|June 27, 2025
Adiponectin Receptor Agonist Suppresses Human Colorectal CancerMai Ly Thi Nguyen, Lan Anh Bui, Chi Pham, et al.Cancers|March 12, 2020
Haprolid Inhibits Tumor Growth of Hepatocellular Carcinoma through Rb/E2F and Akt/mTOR InhibitionJun Xing, Vikas Bhuria, Khac Cuong Bui, et al.Medicine|August 6, 2023
The diagnostic and prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio on gastric cancer patientsMai Ly Thi Nguyen, Chi Pham, Quoc Vuong Le, et al.Cell Biochemistry and Biophysics|January 19, 2024
Adiponectin Receptor Agonist Effectively Suppresses Hepatocellular Carcinoma GrowthMai Ly Thi Nguyen, Chi Pham, Van Tran Pham, et al.Pageof 2